These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10764969)

  • 1. Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.
    Wong SS; Ng TK; Yam WC; Tsang DN; Woo PC; Fung SK; Yuen KY
    Diagn Microbiol Infect Dis; 2000 Apr; 36(4):261-8. PubMed ID: 10764969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.
    Naimi TS; Anderson D; O'Boyle C; Boxrud DJ; Johnson SK; Tenover FC; Lynfield R
    Clin Infect Dis; 2003 Jun; 36(12):1609-12. PubMed ID: 12802763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
    Hanaki H; Kuwahara-Arai K; Boyle-Vavra S; Daum RS; Labischinski H; Hiramatsu K
    J Antimicrob Chemother; 1998 Aug; 42(2):199-209. PubMed ID: 9738837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus.
    Nishi H; Komatsuzawa H; Yamada S; Fujiwara T; Ohara M; Ohta K; Sugiyama M; Ishikawa T; Sugai M
    Microbiol Immunol; 2003; 47(12):927-35. PubMed ID: 14695442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus.
    Sieradzki K; Tomasz A
    J Bacteriol; 1999 Dec; 181(24):7566-70. PubMed ID: 10601215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Oct; 51(40):902. PubMed ID: 12418544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
    Sakoulas G; Gold HS; Venkataraman L; DeGirolami PC; Eliopoulos GM; Qian Q
    J Clin Microbiol; 2001 Nov; 39(11):3946-51. PubMed ID: 11682512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus.
    Wu SW; de Lencastre H; Tomasz A
    J Bacteriol; 2001 Apr; 183(8):2417-24. PubMed ID: 11274099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of different detection methods for methicillin resistance in Staphylococcus aureus].
    Soloaga R; Procopio A; Aguilar J; Dutruel A; Labat R; Domínguez M; Vázquez M; Liñares J; Defain V
    Rev Argent Microbiol; 2002; 34(1):52-6. PubMed ID: 11942084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.
    Finan JE; Archer GL; Pucci MJ; Climo MW
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3070-5. PubMed ID: 11600358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of mutation in the region (nt. 710-1010) of pbp4 gene in clinical isolates of Staphylococcus aureus with low-level teicoplanin resistance.
    Park Y; Oh EJ; Lee SO; Kim BK
    Diagn Microbiol Infect Dis; 2001 Apr; 39(4):271-3. PubMed ID: 11404074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarity of antibiotic resistance patterns and molecular typing properties of methicillin-resistant Staphylococcus aureus isolates widely spread in hospitals in New York City and in a hospital in Tokyo, Japan.
    Aires de Sousa M; de Lencastre H; Santos Sanches I; Kikuchi K; Totsuka K; Tomasz A
    Microb Drug Resist; 2000; 6(3):253-8. PubMed ID: 11144426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of vancomycin-resistant in Staphylococcus aureus].
    Kuroda M; Hiramatsu K
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(8):1329-38. PubMed ID: 10846471
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ; Traynor EA; Griggs DJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones.
    Crisóstomo MI; Westh H; Tomasz A; Chung M; Oliveira DC; de Lencastre H
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9865-70. PubMed ID: 11481426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance.
    Yoshida R; Kuwahara-Arai K; Baba T; Cui L; Richardson JF; Hiramatsu K
    J Antimicrob Chemother; 2003 Feb; 51(2):247-55. PubMed ID: 12562688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.